NanoViricides Inc. (NNVC)

[KMBJN]

Regarding if they can make a successful coronaviricide, yes it's hard to predict. Ebolacide didn't work very well, but Ebola had an unusual shape, so not sure if that played into it or not. Many of their other drugs were successful when tested in cells and animals, including flucide and herpecide. So, based on the consistency of the success in cells and animals, there are decent odds that they can make a coronaviricide that works in cells and animals.

Whether they can get government funds or not, they have a poor record - depending on whether or not Seymour was forthcoming in describing how close they were to previous funds from the feds.

All developmental stage biotechs are failures until they prove their drugs are safe and effective in clinical trials in humans, get FDA approval, sell their drugs at a profit, and make money for investors.

So they are all consistently failures with accumulated losses for many years until they are not.

Most fail.

NNVC has failed to even get an IND and their drugs into humans, which is pretty bad. This is likely to be the next step for them - to test herpecide in humans.

They have been successful testing their drugs in cells and animals, but that is only the first step.

Will see how far they get.

"It's tough to make predictions, especially about the future."